Alembic Pharmaceuticals Current Share Price | Alembic Pharmaceuticals Stock Screener
APLLTD
Pharmaceuticals
Alembic Pharmaceuticals Current Stock Price Today
Live Share Price NSE
₹845.75
▲
19.75 (2.39%)
Live Share Price BSE
₹845.70
▲
19.40 (2.35%)
As of September 18, 2026, the live Alembic Pharmaceuticals share price (NSE: APLLTD) is ₹845.75 on NSE and ₹845.70 on BSE, up 2.39% from the previous close, with shares trading between ₹828.00 and ₹860.00 in today's trading session, and a 52-week range of ₹646.55–₹960.70.
Browse APLLTD cash flow statement to support your investment research.
Use the Alembic Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Alembic Pharmaceuticals Market Cap
₹15,940.29 Cr.
APLLTD P/E Ratio (TTM)
23.29
Alembic Pharmaceuticals P/B Ratio
2.83
EPS (TTM)
₹34.33
Dividend Yield
1.47%
Debt to Equity
0.25
APLLTD 52 Week High
₹960.70
Alembic Pharmaceuticals 52 Week Low
₹646.55
Operating Margin
11.00%
Profit Margin
10.78%
APLLTD Revenue (TTM)
₹1,874.00
EBITDA
₹230.00
Net Income
₹202.00
Total Assets
₹8,763.00
Total Equity
₹5,669.00
Alembic Pharmaceuticals Current Share Price Chart
Track the current Alembic Pharmaceuticals share price and stock price with an interactive chart. Analyse APLLTD price trends, trading volume, historical performance, and volatility across different timeframes — the complete Alembic Pharmaceuticals stock quote in one place.
Alembic Pharmaceuticals Company Profile - Fundamental Screener
Screen Alembic Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for APLLTD shares.
Alembic Pharmaceuticals is an India-based company that manufactures and markets generic pharmaceutical products globally. It operates in India Formulations, International Generics, and Active Pharmaceutical Ingredients (API) segments. The company has state-of-the-art research and manufacturing facilities approved by regulatory authorities, including the US FDA. Alembic produces a range of generics across...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
C R Amin
ISIN
INE901L01018
Alembic Pharmaceuticals Balance Sheet Screener
Screen APLLTD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 8,763 | 7,773 | 6,446 | 6,183 | 7,122 | 6,709 | 5,989 | 4,778 | 3,941 | 2,689 |
| Current Assets | 4,543 | 4,088 | 3,079 | 2,910 | 2,861 | 2,652 | 2,463 | 1,958 | 1,825 | 1,373 |
| Fixed Assets | 3,081 | 2,524 | 2,547 | 2,398 | 1,798 | 1,788 | 1,552 | 1,159 | 993 | 799 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 500 | 171 | 172 | 175 | 168 | 361 | 1,047 | 570 | 576 | 94 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 5,669 | 5,190 | 4,818 | 4,371 | 5,238 | 5,067 | 3,190 | 2,718 | 2,220 | 1,902 |
| Share Capital | 39 | 39 | 39 | 39 | 39 | 39 | 38 | 38 | 38 | 38 |
| Reserves & Surplus | 5,636 | 5,152 | 4,779 | 4,331 | 5,198 | 5,028 | 3,182 | 2,681 | 2,182 | 1,865 |
Alembic Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Alembic Pharmaceuticals income statement and profit fundamentals.
Analyze APLLTD quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Alembic Pharmaceuticals share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,874 | 2,165 | 1,784 | 1,717 | 1,919 | 1,892 | 1,521 | 1,564 | 1,678 | 1,703 | 1,407 | 1,498 | 1,605 | 1,634 | 1,426 |
| Expenses | 1,645 | 1,818 | 1,498 | 1,430 | 1,595 | 1,627 | 1,257 | 1,325 | 1,409 | 1,433 | 1,203 | 1,288 | 1,387 | 1,364 | 1,268 |
| EBITDA | 230 | 347 | 286 | 287 | 324 | 265 | 263 | 239 | 270 | 270 | 205 | 210 | 218 | 269 | 158 |
| Operating Profit % | 11.00% | 15.00% | 15.00% | 16.00% | 17.00% | 13.00% | 17.00% | 15.00% | 15.00% | 15.00% | 14.00% | 13.00% | 13.00% | 16.00% | 10.00% |
| Depreciation | 89 | 98 | 69 | 74 | 76 | 80 | 70 | 69 | 71 | 70 | 74 | 66 | 68 | 69 | 123 |
| Interest | 23 | 28 | 25 | 24 | 24 | 23 | 11 | 13 | 19 | 22 | 14 | 14 | 16 | 15 | 7 |
| Profit Before Tax | 119 | 222 | 192 | 190 | 224 | 162 | 183 | 157 | 180 | 178 | 116 | 130 | 135 | 185 | 29 |
| Tax | -83 | 50 | 35 | 37 | 40 | 30 | 5 | 23 | 27 | 40 | -36 | 9 | -2 | 4 | 7 |
| Net Profit | 202 | 172 | 157 | 154 | 184 | 132 | 178 | 135 | 153 | 138 | 153 | 121 | 137 | 180 | 22 |
| EPS | 10.31 | 8.80 | 7.98 | 7.85 | 9.40 | 6.76 | 9.07 | 6.84 | 7.79 | 7.01 | 7.76 | 6.14 | 6.95 | 9.23 | 1.11 |
Alembic Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen APLLTD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 783 | 88 | 803 | 724 | 552 | 1,463 | 449 | 812 | 312 | 329 |
| Investing Activities | -506 | -568 | -321 | -448 | -372 | -840 | -731 | -756 | -884 | -486 |
| Financing Activities | -164 | 444 | -438 | -262 | -217 | -597 | 155 | 59 | 503 | -129 |
| Net Cash Flow | 113 | -37 | 45 | 14 | -37 | 26 | -127 | 115 | -69 | -286 |
Alembic Pharmaceuticals Shareholding Pattern Screener
See Alembic Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Alembic Pharmaceuticals promoter holding and ownership changes for APLLTD on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 69.74% | 69.87% | 69.67% | 69.67% | 69.74% | 69.74% | 69.61% | 69.61% |
| FII Holding | 4.25% | 4.18% | 3.94% | 3.96% | 4.05% | 4.24% | 4.46% | 4.32% |
| DII Holding | 16.18% | 15.94% | 16.43% | 16.46% | 16.30% | 16.17% | 15.38% | 15.47% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.86% | 6.97% | 7.07% | 7.01% | 6.93% | 6.87% | 7.41% | 7.48% |
| Other Holding | 2.96% | 3.03% | 2.88% | 2.89% | 2.99% | 2.98% | 3.14% | 3.13% |
| Shareholder Count | 86,432 | 86,796 | 91,336 | 89,013 | 89,969 | 87,000 | 76,567 | 74,829 |
Alembic Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Alembic Pharmaceuticals dividend history with payout and yield data.
View Alembic Pharmaceuticals dividend details including ex-dates and amounts for APLLTD stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹12.00 | 1.48% |
| 2025-March | ₹11.00 | 1.66% |
| 2024-March | ₹11.00 | 1.18% |
| 2023-March | ₹8.00 | 0.81% |
| 2022-March | ₹10.00 | 2.13% |
| 2021-March | ₹14.00 | 1.89% |
| 2020-March | ₹10.00 | 1.04% |
| 2019-March | ₹5.50 | 1.03% |
| 2018-March | ₹4.00 | 0.74% |
| 2017-March | ₹4.00 | 0.73% |
Alembic Pharmaceuticals Stock Index Membership
See which indices include Alembic Pharmaceuticals stock.
Check APLLTD index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
Alembic Pharmaceuticals Market Events Screener - Corporate Actions
Get Alembic Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Alembic Pharmaceuticals stock events that may affect APLLTD share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-05 | 2026-08-05 | Annual General Meeting | NA | -0.83% |
| 2026-08-04 | 2026-08-04 | Quarterly Result Announcement | NA | 1.47% |
| 2026-07-29 | 2026-07-29 | Dividend | ₹ 12.00 /share | 4.12% |
| 2026-05-15 | 2026-05-15 | Quarterly Result Announcement | NA | 4.71% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 3.71% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | -0.92% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -6.22% |
| 2025-08-05 | 2025-08-05 | Annual General Meeting | NA | -1.57% |
| 2025-07-29 | 2025-07-29 | Dividend | ₹ 11.00 /share | 10.49% |
| 2025-05-06 | 2025-05-06 | Quarterly Result Announcement | NA | 6.54% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -9.02% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | -3.68% |
| 2024-07-22 | 2024-07-22 | Annual General Meeting | NA | 27.73% |
| 2024-07-15 | 2024-07-15 | Dividend | ₹ 11.00 /share | -1.72% |
| 2023-07-28 | 2023-07-28 | Dividend | ₹ 8.00 /share | 30.61% |
Alembic Pharmaceuticals Competitors Screener - Peer Comparison
Screen APLLTD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Alembic Pharmaceuticals Company Announcements - News Screener
Screen APLLTD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-17 | Intimation Regarding Successful Completion Of Unannounced USFDA Onsite Bioequivalence Inspection. | - |
| 2026-09-13 | Intimation Under Regulation 30 Of SEBI LODR Regulations 2015 - Incorporation Of A Wholly Owned Subsidiary Company | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-20 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-06 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-05 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-04 | Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-04 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-07-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |